Search
Analyze the current clinical applications, market potential, and regulatory challenges of digital therapeutics and remote monitoring systems in the prevention of cardiovascular diseases (such as hypertension and dyslipidemia). Discuss the evolution trends from single-function applications to integrated digital ecosystems.
In-depth analysis of the current status of AI realizing commercial value in the healthcare sector. This article examines how AI drives returns on investment in core fields such as medical imaging and drug discovery from the perspectives of enterprise applications, technological trends, and market impact.
Analyze the research, clinical trials, and approval trends in the current medical device innovation field, explore how private and medium-sized enterprises can change traditional innovation paths, and look ahead at the driving forces of AI and digital health for the future growth of medical devices.
In-depth analysis of the 26 key trends driven by biotechnology and life sciences in 2026, covering the core position of AI in R&D, the explosion of synthetic biology, the clinical application of gene editing, and profound changes in global regulatory policies.
In-depth analysis of how the medical industry is moving AI from experimentation to implementation, exploring the driving forces behind generative AI and open-source models, as well as the return on investment (ROI) for medical AI in core fields such as imaging and drug discovery.
In-depth analysis of how AI technology is reshaping the healthcare sector, covering AI applications in diagnosis and drug development, key market trends, and regulatory challenges, providing a forward-looking perspective for the medical technology industry.
In-depth analysis of the regulatory challenges brought by AI in digital health and medical devices. This paper discusses the risks of AI whitewashing, FDA guidance on new methodologies, and the impact of global data privacy policies on Biotech Innovation and Digital Health platforms.
Analyzing the accelerated convergence of AI, digital health, and medical regulation. Discussing the latest developments from agencies like the FDA and EU, as well as opportunities, AI cleansing risks, and future directions for enterprises in AI medical applications.
In-depth analysis of how the global healthcare industry can leverage AI technology to achieve investment returns, covering the latest trends and capital flows in the digital health, AI in healthcare, and medical device sectors.
In-depth analysis of the core applications of medical AI in diagnostic assistance, drug discovery, and digital health platforms, exploring its driving role in the medical equipment and health technology industries, and examining regulatory challenges.
Analyze the Deloitte 2026 Life Sciences Outlook Report, exploring how AI, digital health platforms, and medical devices are reshaping the growth trajectory, market confidence, and regulatory challenges of the global healthcare industry.
In-depth analysis of how cutting-edge technologies such as AI medical large models, digital health platforms, and medical devices are reshaping the global healthcare industry landscape, and exploring the future development trends of Digital Health and AI Healthcare.
In-depth analysis of the current application status, key technological development trends, and regulatory challenges faced by AI in the healthcare sector (Digital Health, Medical Devices, Biotech Innovation), and exploring how technology drives changes in the medical system.
In-depth analysis of how medical AI technology achieves significant return on investment by improving the efficiency of medical imaging diagnosis and drug development. Focusing on the industry implementation trends of Digital Health and Medical AI.
From the FDA's Predetermined Change Control Plan to the EU AI Act's risk classification, a review published in *Frontiers in Medicine* systematically mapped the regulatory pathways for AI medical devices across five major markets—the United States, the European Union, China, Japan, and South Korea—over a decade, while also exposing structural gaps in clinical validation and data diversity.
This article analyzes the implementation progress of AI healthcare, enterprise strategies, market impact, regulatory challenges, and development trends over the next 3-5 years from the perspective of global medical technology industry media, helping industry readers grasp the pulse of Healthcare Innovation.
According to a report by Healthcare Foresights, the global healthcare digital transformation market is expected to reach $270.9 billion by 2035, with a compound annual growth rate of 14.13%. AI, cloud computing, and telemedicine are accelerating the transformation of the healthcare system.
According to the latest forecast from Precedence Research, the global digital health market size is expected to reach $1.17 trillion by 2035, with a CAGR of 10.8%. Telemedicine, AI applications, and service models are reshaping the landscape of the healthcare industry.
This article is based on Salesforce's latest industry insights, analyzing the core applications, industry trends, market impact, and potential challenges of AI in healthcare, and exploring the industrial path of medical AI evolving from an assistive tool to healthcare system infrastructure.
The global healthcare IT market is expected to grow from USD 246.17 billion in 2024 to USD 502.91 billion in 2035, with a compound annual growth rate of 6.71%. Telemedicine, data interoperability, and AI applications are the key drivers.
According to Market.us Media data, the global digital health market is expected to reach $2.19 trillion by 2034, with $287.8 billion in 2024, representing a compound annual growth rate of 22.5%. North America dominates the market, while Asia-Pacific is growing the fastest, with telemedicine, medical AI, and wearable devices becoming core drivers.
Medical AI has moved from experimentation to clinical practice, but the practical application of diagnosis, treatment, and decision support still faces challenges in data, trust, and integration. This article reviews the current state and future trends.
This article reviews the important developments in the global medical technology sector during the third week of April 2025, covering financing, FDA approvals, clinical trials, and M&A collaborations, and analyzes the impact of technological trends such as neural interfaces, AI-assisted diagnosis, and leadless pacing on the industry.
The U.S. FDA has announced that Dexcom is the first participant in its TEMPO Digital Health Pilot Program, which allows certain digital health devices to be exempt from premarket review while collecting real-world data through Medicare. Dexcom plans to use AI and continuous glucose monitoring technology to screen for prediabetes and type 2 diabetes, marking a deep integration of regulatory innovation and payment reform.
AI is reshaping the healthcare industry, from diagnostic assistance to patient management, with technology implementation accelerating. This article analyzes key trends, market impacts, and future challenges.
A comprehensive analysis of AI in healthcare adoption statistics for 2025-2026, covering market size, ROI, FDA clearances, and the widening gap between administrative and clinical diagnostic use.
Discuss the impact of AI on employment in the healthcare industry, analyzing which positions are at risk, which are safe, and the new opportunities created by AI.
PanopticAI obtains FDA's second 510(k) for contactless respiratory rate monitoring; Coreline Soft partners with Mint Medical to advance lung cancer screening AI in Germany; AIRS Medical receives strategic investment to accelerate MRI innovation; QuantumTX and Kaopiz join forces to develop AI-driven preventive healthcare solutions.
In recent HIMSS TV discussions, doctors at Samsung Medical Center emphasized that if healthcare systems position infrastructure modernization as an effort to improve the clinical experience rather than as a mere IT project, they are more likely to gain physician support and drive the adoption of new technologies. This approach is reshaping the procurement logic for Digital Health, Healthcare Technology, and AI Healthcare.
GE HealthCare will showcase AI software, imaging systems, radiopharmaceuticals, and localized production solutions related to nuclear medicine during SNMMI 2026, reflecting that nuclear medicine is moving from competition among single devices toward a phase of expansion driven by “platformization + ecosystemization.”